Vigabatrin
≥98%
- Product Code: 103210
CAS:
68506-86-5
| Molecular Weight: | 129.16 g./mol | Molecular Formula: | C₆H₁₁NO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Vigabatrin is primarily used in the treatment of epilepsy, specifically for managing refractory complex partial seizures in adults and infantile spasms in children. It works by increasing the levels of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve activity in the brain, thereby reducing seizure activity. In cases of infantile spasms, it is often considered when other treatments have failed or are not suitable. Due to its potential side effects, particularly irreversible vision loss, its use is carefully monitored, and it is typically prescribed when the benefits outweigh the risks. Regular ophthalmologic evaluations are required for patients undergoing treatment to detect any early signs of vision impairment.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To White W/ Yellow Cast Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
| Solubility (Solvent) | Water |
| Solubility (Conc) | 19.60-20.40 mg/ml |
| Solubility (Turbidity) | Clear |
| Solubility (Color) | Colorless To Faint Yellow |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿6,990.00 |
+
-
|
| 0.010 | 10-20 days | ฿11,790.00 |
+
-
|
Vigabatrin
Vigabatrin is primarily used in the treatment of epilepsy, specifically for managing refractory complex partial seizures in adults and infantile spasms in children. It works by increasing the levels of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve activity in the brain, thereby reducing seizure activity. In cases of infantile spasms, it is often considered when other treatments have failed or are not suitable. Due to its potential side effects, particularly irreversible vision loss, its use is carefully monitored, and it is typically prescribed when the benefits outweigh the risks. Regular ophthalmologic evaluations are required for patients undergoing treatment to detect any early signs of vision impairment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :